NATALIE HOLLOBAUGH: Open Payments
NPI 1821843103 · MIDDLE RIVER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,120 in 92 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,385 · 2025 $2,120
Food & beverage: $2,008Education: $111
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $356 |
| ABBVIE INC. | 22 | $282 |
| Teva Pharmaceuticals USA, Inc. | 6 | $220 |
| Neurocrine BioSciences, Inc. | 7 | $196 |
| E.R. Squibb & Sons, L.L.C. | 10 | $187 |
| Almatica Pharma LLC | 7 | $176 |
| Alkermes, Inc. | 8 | $171 |
| Lundbeck LLC | 5 | $123 |
| Axsome Therapeutics, Inc. | 5 | $95 |
| Otsuka America Pharmaceutical, Inc. | 4 | $83 |
Products named: CAPLYTA, VRAYLAR, REXULTI, INGREZZA, COBENFY, LOREEV XR, ARISTADA, Auvelity.
Industry payments across MD — which companies pay providers there.
